In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases.
Sala A, Caminiti SP, Presotto L, Pilotto A, Liguori C, Chiaravalloti A, Garibotto V, Frisoni GB, D'Amelio M, Paghera B, Schillaci O, Mercuri N, Padovani A, Perani D.
Sala A, et al. Among authors: caminiti sp.
Alzheimers Res Ther. 2021 Nov 12;13(1):187. doi: 10.1186/s13195-021-00925-1.
Alzheimers Res Ther. 2021.
PMID: 34772450
Free PMC article.